Evidence map›Paper›PMID 40823609›Full record

ArticleDiabetes spectrum : a publication of the American Diabetes Association2025

Persistent Performance Improvement Using Team Resources and Continuous Glucose Monitoring in Patients With Poorly Controlled Type 2 Diabetes.

Andrew Behnke, Kara S Lucas, Christopher G Parkin, Varsha Reddy, Michele Orlowski, Ailene Edwards

Abstract read
In one paragraph

Article in Diabetes spectrum : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew BehnkeCarilion Clinic, Roanoke, VA.ORCID https://orcid.org/0000-0002-4970-6536
Kara S LucasEndocrinology Ambulatory Clinical Pharmacist, Carilion Clinic, Roanoke, VA.ORCID https://orcid.org/0009-0004-3434-188X
Christopher G ParkinCGParkin Communications, Henderson, NV.ORCID https://orcid.org/0000-0001-6838-5355
Varsha ReddyCollege of Medicine, University of South Carolina, Charleston, SC.
Michele OrlowskiCentral Virginia Family Physicians, Lynchburg, VA.
Ailene EdwardsVirginia Tech Carilion School of Medicine, Roanoke, VA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study was to assess the impact of an interdisciplinary diabetes care team approach using continuous glucose monitoring (CGM) on glycemic outcomes in a population of adults with type 2 diabetes with suboptimal glycemic control. RESEARCH DESIGN AND

methodsThis 6-month, longitudinal observational study was conducted at the outpatient endocrinology clinic of Carilion Clinic in Roanoke, VA. The intervention included use of CGM and weekly interactions either virtually or by telephone by one of the team members. The primary outcomes were changes in A1C, average glucose, and glycemic time in range (TIR; 70-180 mg/dL) over the 6-month observation period. Changes in diabetes medications were also assessed.

resultsTwenty-one adults with type 2 diabetes and a baseline A1C >9% were included in the analysis. At 6 months, A1C levels decreased from 11.3 to 7.6%, average glucose decreased from 212.8 to 159.5 mg/dL, and TIR increased from 44.5 to 67.7%.

conclusionThese results suggest that an interdisciplinary team approach in combination with CGM and frequent interaction is effective in improving glycemic outcomes in a high-risk population. Studies of longer duration are needed to further elucidate the efficacy of this intervention.

Identifiers

PMID40823609
PMCPMC12357217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.